Does NILOTINIB Cause Dyslipidaemia? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Dyslipidaemia have been filed in association with NILOTINIB (nilotinib). This represents 0.3% of all adverse event reports for NILOTINIB.
70
Reports of Dyslipidaemia with NILOTINIB
0.3%
of all NILOTINIB reports
3
Deaths
10
Hospitalizations
How Dangerous Is Dyslipidaemia From NILOTINIB?
Of the 70 reports, 3 (4.3%) resulted in death, 10 (14.3%) required hospitalization, and 9 (12.9%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NILOTINIB. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which NILOTINIB Alternatives Have Lower Dyslipidaemia Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB